GLYCOPYRRONIUM-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
GLYCOPYRRONIUM-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 (255 working days)
Registration type
New generic medicine
Indication
- As a preoperative antimuscarinic to reduce salivary, tracheobronchial and pharyngeal secretions, and to reduce the acidity and volume of the gastric contents.
- As a preoperative or intra-operative antimuscarinic to attenuate or prevent intraoperative bradycardia associated with the use of suxamethonium or due to cardiac vagal reflexes.
- To protect against the peripheral muscarinic actions (e.g. bradycardia and excessive secretions) of anticholinesterases such as neostigmine or pyridostigmine given to reverse neuromuscular blockade produced by non-depolarising muscle relaxants.